Author

Isabella van der Feltz

Institutions: Radboud University Nijmegen, Radboud University Medical Center

Observed institutions: Radboud University Nijmegen, Radboud University Medical Center

ORCID: 0000-0002-3769-2042

Observed ORCID: 0000-0002-3769-2042

OpenAlex ID: A5115080121

Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial

2025 · Lilian Tina Minja, Isabella van der Feltz, et al. · The Lancet Infectious Diseases · 18

Studying intrapulmonary pharmacokinetics for tuberculosis treatment: a systematic review of methodology

2025 · Isabella van der Feltz, Haini Wen, et al. · Journal of Antimicrobial Chemotherapy · 5

A Prospective, Randomised, Open Label Phase 2b Dose-Finding Trial of Delpazolid in Combination with Bedaquiline, Delamanid and Moxifloxacin for Pulmonary Tuberculosis: DECODE

2024 · Lilian Tina Minja, Isabella van der Feltz, et al. · SSRN Electronic Journal

Works count: 3

Citation count: 23

H-index: 2

I10-index: 1